Aug 13, 2026 · Sports, Health & Nutrition Daily Digest
Daily digest of exercise, wellness, and nutrition developments for Aug 13, 2026, with summaries, links, and commentary.
I. Nutrition & Diet
1. Harvard cohorts: healthy plant-based diets track lower CVD, diabetes, and death risk almost regardless of processing (Nutrition)
Summary:
Xiaowen Wang and colleagues at the Harvard T.H. Chan School of Public Health presented an as-yet un-peer-reviewed cohort analysis at NUTRITION 2026 (American Society for Nutrition, July 25–28): Nurses' Health Studies I/II and the Health Professionals Follow-up Study, about 160,690 women and 42,585 men, crossed plant-based diet indices (healthy hPDI / unhealthy uPDI) with ultra-processed food (UPF) status. Highest versus lowest quintiles: UPF-hPDI and non-UPF-hPDI showed CVD HRs of about 0.86 and 0.82, type 2 diabetes about 0.67 and 0.66, and mortality about 0.89 and 0.93; unhealthy plant-based patterns raised CVD and diabetes risk whether or not foods were UPF. Follow-up captured about 26,209 CVD cases, 21,006 T2D cases, and 55,493 deaths. Hematology Advisor and Healio recapped the work from late July through Aug 12. Observational meeting abstract—not proof that "processing is harmless."
Links:
- Medical Xpress / ASN — Diet quality outweighs processing level
- Healio — Healthy plant-based diets and processing
Commentary:
Judge the grocery cart by whole grains, produce, legumes, nuts, and plant oils first; fortified plant milk and whole-grain bread can stay, while chips and juice do not become "healthy plants" just because they are less processed.
2. 18-month RCT: green Mediterranean diet raises serum folate more than standard MED, with an MTHFR genotype interaction (Nutrition)
Summary:
A DIRECT-PLUS secondary analysis in Clinical Nutrition (DOI: 10.1016/j.clnu.2026.106701) randomized 294 adults with abdominal obesity or dyslipidemia to healthy dietary guidelines (HDG), Mediterranean (MED), or plant-forward green-MED diets. Both isocaloric MED arms included 28 g walnuts/day; green-MED also avoided red/processed meat and added a 500 ml/day Wolffia globosa (Mankai) shake plus 3–4 cups of green tea. Eighteen-month retention was 89%; baseline folate deficiency was rare (~3%). Green-MED raised serum folate by +1.2 ng/mL versus +0.41 (MED) and +0.1 (HDG), p<0.05 between groups; higher Mankai intake tracked folate gains (p=0.003). MTHFR rs1801133 TT carriers (~11.7%) had lower folate before and after the trial; CC/CT carriers showed the largest green-MED increase. The sample was mostly middle-aged men—not a mandate to drink Mankai.
Links:
- Clinical Nutrition — Green-MED and serum folate (DOI)
- Ben-Gurion University — DIRECT PLUS folate and MTHFR
Commentary:
Swap red meat for legumes, leafy greens, nuts, and tea polyphenols before ordering an MTHFR panel or a specialty duckweed shake—the RCT tested a pattern, not a single superfood.
3. Birth cohort: higher HFCS and apple-juice intake associated with incident childhood asthma and ER visits (Nutrition / Public health)
Summary:
Published Aug 11, 2026 in Scientific Reports, DeChristopher and Tucker analyzed the U.S. Early Childhood Longitudinal Study–Birth Cohort (roughly birth to age 5, children born in 2001, weight-adjusted) with Cox models for HFCS and 100% juice versus asthma and asthma ER visits/hospitalizations. Apple juice, high in unpaired fructose, is the most consumed juice in this age group. Dose–response appeared for HFCS/100% juice with asthma (P-trend <0.001) and ER/hospitalization (P-trend=0.001), including at moderate intake (3 times/week); asthma risk rose about 15%–43% and ER/hospitalization about 60%–106%, with incidence and incident cases per 1,000/year also increasing. Observational; mechanistic claims lean on animal, in vitro, and prior trial data and cannot treat one juice serving as proof of causation.
Links:
Commentary:
Default toddler drinks to water and whole fruit; treating 100% juice as a vitamin vehicle or HFCS sodas as a daily habit is a faster risk cut than debating fructose biochemistry.
4. PNAS: too few vegetable species on plates; vegetable biodiversity is needed for intake and climate resilience (Nutrition / Public health)
Summary:
On Aug 13, 2026, Eric Schranz, Anna Herforth, and colleagues at Wageningen University published in the Proceedings of the National Academy of Sciences: global vegetable intake sits nearly 40% below WHO recommendations, low vegetable intake ranks among the five leading dietary risks for disease burden, and more than one in three people cannot afford a healthy diet. The team catalogs more than 1,480 edible vegetable species, most under-researched versus staple crops; almost one-quarter of assessed wild relatives of major vegetable crops are threatened with extinction. Examples include spider plant in Africa, bitter melon in Asia, slippery cabbage in the Pacific, and edible leaves of pumpkin, sweet potato, and cowpea. Four priorities: conserve, breed, put diversity on plates, and embed it in policy. Policy–biodiversity synthesis, not an individual-dose RCT.
Links:
- Phys.org — Vegetable diversity and healthier diets (2026-08-13)
- PNAS — Reversing vegetable biodiversity loss (DOI)
Commentary:
Rotate local seasonal greens, pods, and bitter melon–type vegetables into the week rather than buying another imported "superfood" powder—the paper's action is variety on the plate, not a new capsule.
II. Exercise & Training Science
5. 8-week RCT: high-intensity interval cross-training beat classical training on 100-m and power marks in junior male sprinters (Training)
Summary:
Published Aug 3, 2026 in PLOS One, 64 male junior sprinters (baseline age ~17.5 years, 100-m ~11.46 s) were randomized to high-intensity interval cross-training (HIICT: sprints plus plyometrics plus functional strength) or classical training (CT) for 8 weeks with comparable internal load (session-RPE). HIICT improved 100-m time by about −0.24 s versus −0.08 s for CT (group × time p<0.001); first-60-m split about −0.19 s versus −0.06 s; ground-contact time fell only in HIICT; CMJ about +4.68 cm versus −0.18 cm; Wingate peak power about +37.22 W versus +2.78 W. Squat jump rose in both groups, slightly more after HIICT. Single-center adolescent male sample; authors call for independent replication.
Links:
Commentary:
Recreational runners need not copy a junior sprint syllabus; if you already run, folding short intervals with jumps and strength into the same session tracks this RCT better than endless straight-line repeats.
III. Public Health & Disease Prevention
6. JAHA analysis: under 2025 hypertension guidance and PREVENT, about 9.7 million U.S. adults are eligible for BP drugs but untreated (Public health)
Summary:
Mustafa Al-Jarshawi and colleagues at Keele University published July 29, 2026 in the Journal of the American Heart Association (DOI: 10.1161/JAHA.125.048616); CNN recapped Aug 12. Using NHANES 2009–2018, about 81 million U.S. adults had high blood pressure without baseline CVD; about 22.8 million (28%) were newly medication-eligible under the 2025 AHA/ACC guideline (BP ≥130/80 mmHg plus PREVENT 10-year CVD risk ≥7.5%, diabetes, or CKD), and about 9.7 million remained untreated. Treatment was associated with about 23% lower all-cause and 50% lower cardiovascular mortality versus no treatment; covering all untreated eligible adults was projected to avert about 200,900 all-cause and 162,600 cardiovascular deaths over 10 years. Single-visit office BP and observational projection—not a randomized trial.
Links:
- AHA newsroom — PREVENT and the hypertension treatment gap
- CNN — Untreated high blood pressure and medication eligibility (2026-08-12)
Commentary:
If home readings repeatedly hit ≥130/80, start sodium control, weight management, and 150 minutes of aerobic activity plus strength; with diabetes, kidney disease, or non-low 10-year risk, talk with a clinician about starting medication rather than "watching it" indefinitely.
7. CDC advisory: severe arboviral disease risk is higher in people on B-cell–depleting or modulating drugs (Public health)
Summary:
CDC issued HAN Health Advisory CDCHAN-00532 on Aug 11, 2026 (AHA News recap Aug 12): patients receiving B-cell–depleting or modulating therapies—especially anti-CD20 monoclonal antibodies (rituximab and biosimilars, ocrelizumab, ofatumumab, ublituximab, obinutuzumab, ibritumomab tiuxetan)—face elevated risk of severe neuroinvasive arboviral disease (West Nile most common). Published case series report roughly 40% overall mortality, with most survivors left with neurologic sequelae. Impaired antibody responses mean diagnosis should prioritize molecular tests (RT-PCR or metagenomic sequencing) over serology. No approved human vaccines or specific prophylactics exist for U.S.-endemic arboviruses. The advisory coincides with an early, intense West Nile season.
Links:
Commentary:
If you or a family member is on rituximab-class drugs, treat mosquito and tick prevention this season like hand hygiene; tell clinicians about the drug if fever, headache, weakness, or confusion appears so they do not rely on antibody tests alone.
IV. Sleep & Mental Health
8. Meta-analysis of 8 RCTs: insomnia-focused psychological and behavioral care eases depressive symptoms in youth (Sleep / Mental health)
Summary:
A systematic review and meta-analysis published Aug 6, 2026 in European Child & Adolescent Psychiatry searched through Dec 30, 2025 and pooled 8 RCTs (904 children and adolescents; mean age ~13.46 years) of insomnia-focused psychological/behavioral interventions, including CBT-I, versus controls on depressive symptoms. Interventions outperformed controls (SMD=0.238, 95% CI 0.088–0.387, p=0.0019); delivery format (including digital) and setting did not significantly moderate effects; completion was about 87%. Modest effect and few trials—not a substitute for specialty care in moderate-to-severe depression.
Links:
Commentary:
When a child's mood drops, lock in a regular wake time, limit naps, and keep the bed for sleep before reaching for melatonin; persistent insomnia or self-harm thoughts need a clinician, not a "just sleep it off" plan.
V. Evidence & Clarification
9. Meta-analysis of 15 RCTs: personalized nutrition trims weight and fat only slightly versus standard advice; no extra lipid or glucose benefit (Evidence)
Summary:
Published May 9, 2026 in Nutrition & Metabolism (search through March 1, 2026): 15 RCTs in 2,351 adults with overweight or obesity required at least one biological input (genetics, metabolic markers, or microbiome) to guide personalized advice. Versus non-personalized dietary counseling, personalized nutrition reduced body weight by MD −1.27 kg (95% CI −2.38 to −0.16) and body fat by −0.44% (−0.76 to −0.12); BMI, waist circumference, lipids, and glycemic markers did not differ, nor did energy or macronutrient intake. GRADE ranged from moderate to very low with high heterogeneity; dropping individual trials could erase the weight/fat signals. Nearly half of controls used a named dietary pattern or withheld counseling.
Links:
Commentary:
Stabilize a Mediterranean- or DASH-style pattern before paying for gene or microbiome meal plans; current RCT pooling buys roughly a kilogram-scale edge and has not rewritten routine metabolic labs.
10. Study-level analysis of 684 RCTs: creatine dose and duration are not tied to clinically meaningful extra side effects (Evidence)
Summary:
Published April 1, 2026 in Sports, investigators analyzed side-effect reporting across creatine monohydrate and placebo arms of 684 randomized trials (more than 12,800 participants). Any reported side effect was uncommon; higher dose or longer duration tertiles showed a weak association with at least one reported event, but effect sizes were small, symptoms were mostly mild and nonspecific, and adjusted models found no consistent exposure–response; placebo arms often reported similar or higher rates. This is study-level, not participant-level, synthesis; evidence in people with kidney disease remains limited.
Links:
Commentary:
Healthy adults can use 3–5 g/day creatine monohydrate from a third-party–tested product without treating "kidney damage" rumors as settled science; established kidney disease or nephrotoxic drugs still belong in a clinician conversation, not a social-media loading protocol.
11. Mice and organoids: dietary vitamin A restricts intestinal tuft-cell differentiation via retinoic acid signaling (Mechanism / Nutrition)
Summary:
Theresa Alenghat's team at Cincinnati Children's published Aug 12, 2026 in Cell Reports: mouse models and intestinal organoids show dietary vitamin A and its metabolite retinoic acid, acting through the retinoic acid receptor and Sprouty2, limit intestinal stem-cell differentiation into tuft cells. Vitamin A deficiency increased tuft cells and type 2 immunity and improved worm clearance in mice; restoring vitamin A reversed the shifts. The institutional write-up posted Aug 13. Animal and in vitro mechanism work—not evidence that restricting vitamin A treats allergy or parasites in humans.
Links:
- Cincinnati Children's — Vitamin A and intestinal immunity (2026-08-13)
- Cell Reports — Dietary vitamin A restricts tuft-cell differentiation
Commentary:
Keep getting vitamin A from dark leafy vegetables, egg yolk, or fortified foods per dietary guidelines; do not cut or megadose vitamin A to "tune tuft cells"—human allergy and parasite outcomes were not tested here.
Today's Summary
- Nutrition puts plant-food quality ahead of processing labels, pairs green-MED folate gains with less sweetened drink/juice, and argues for more vegetable species on the plate.
- Training contributes one junior-sprint RCT: at matched internal load, interval cross-training beat classical running on acceleration and power—extrapolation should stay cautious.
- Public health is the actionable floor: treat high blood pressure by risk stratum, and treat mosquito/tick prevention as part of B-cell drug counseling.
- Sleep and evidence notes: treating youth insomnia can modestly ease depression, while gene/microbiome meal plans and creatine safety data both say do the guideline basics before buying tests or extra pills.
Daily Framing:
Aug 13 reads as a "diet-quality calibration × risk-stratified medication × do not over-extrapolate mechanisms" day—what plants you eat, whether blood pressure drugs are due, and whether a child's insomnia gets behavioral care change outcomes faster than another layer of personalized testing.
This digest is compiled from real-time search results and is for reference only.